Dataset Information


Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

ABSTRACT: This study was undertaken to determine the prevalence and correlates of cognitive impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with Parkinson's disease (PD).Both CI and NPS are common in PD and impact disease course and quality of life. However, limited knowledge is available about cognitive abilities and NPS.Parkinson's Progression Markers Initiative (PPMI) is a multi-site study of early, untreated PD patients and healthy controls (HCs), the latter with normal cognition. At baseline, participants were assessed with a neuropsychological battery and for symptoms of depression, anxiety, impulse control disorders (ICDs), psychosis, and apathy.Baseline data of 423 PD patients and 196 HCs yielded no between-group differences in demographic characteristics. Twenty-two percent of PD patients met the PD-recommended screening cutoff for CI on the Montral Cognitive Assessment (MoCA), but only 9% met detailed neuropsychological testing criteria for mild cognitive impairment (MCI)-level impairment. The PD patients were more depressed than HCs (P?

SUBMITTER: Weintraub D 

PROVIDER: S-EPMC4855523 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4166362 | BioStudies
2020-01-01 | S-EPMC7498017 | BioStudies
2016-01-01 | S-EPMC5375103 | BioStudies
1000-01-01 | S-EPMC4800836 | BioStudies
2013-01-01 | S-EPMC3589192 | BioStudies
2020-01-01 | S-EPMC7749616 | BioStudies
2020-01-01 | S-EPMC7417300 | BioStudies
2020-01-01 | S-EPMC7768013 | BioStudies
2010-01-01 | S-EPMC3049172 | BioStudies
2018-01-01 | S-EPMC5803409 | BioStudies